Wellington Biomedical Innovation Master Investors (Cayman) I L.P. - 28 Jul 2021 Form 3 Insider Report for Nuvalent, Inc. (NUVL)

Role: 10%+ Owner
Signature: Wellington Biomedical Innovation Master Investors (Cayman) I L.P., By: Wellington Management Company LLP, as Investment Advisor, /s/ Jennifer Boylan, Title: Authorized Person
Issuer symbol: NUVL
Transactions as of: 28 Jul 2021
Net transactions value: $0
Form type: 3
Filing time: 28 Jul 2021, 21:29:04 UTC
Previous filing: 22 Jun 2021
Next filing: 03 Aug 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NUVL	Series B Preferred Stock							28 Jul 2021	Class A Common Stock	897,671		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series B Preferred Stock is convertible into 0.1858 shares of the Issuer's Class A Common Stock at any time at the holder's election. Upon the closing of the Issuer's initial public offering, all such shares of Series B Preferred Stock will automatically convert into the number of shares of Class A Common Stock of the Issuer shown in column 3. The Series B Preferred Stock has no expiration date.

Content

Each share of Series B Preferred Stock is convertible into 0.1858 shares of the Issuer's Class A Common Stock at any time at the holder's election. Upon the closing of the Issuer's initial public offering, all such shares of Series B Preferred Stock will automatically convert into the number of shares of Class A Common Stock of the Issuer shown in column 3. The Series B Preferred Stock has no expiration date.